HALIX

HALIX is a fast growing, biopharmaceutical contract development and manufacturing organization (CDMO) focused on viral vector and recombinant protein products. We have recently built a state-of-the-art GMP manufacturing facility at the Bio Science Park in Leiden that is getting filled with exciting new vaccines, antibodies and protein products. At HALIX, we support our customers with the development & commercialization of biologics enabling the treatment & prevention of life threatening conditions such as cancer, COVID-19, influenza and other infectious diseases. Currently we are working on the production of a leading COVID-19 vaccine candidate. If you too would like to contribute to...

Development & manufacturing of biologics,viral vector manufacturing,recombinant protein products,drug substance & drug product,gmp manufacturing,biotechnology,contract manufacturing,therapeutics,and cdmo

Halix operates in the Biotechnology research industry.

Halix's revenue is 11m - 100m

Halix has 51 - 200 employees.